Baird Capital portfolio company OncoHealth, a leading digital health company dedicated to oncology, today announced new strategic investments from Arsenal Capital Partners (“Arsenal”) and McKesson Corporation (“McKesson”). Arsenal will take a majority ownership stake in the business and Baird Capital will retain a minority equity stake in the business; additional financial terms of the transaction were not disclosed.

Baird Capital initially invested in OncoHealth in May 2020 when the Venture team led a $28 million, Series C financing round. The new investments from Arsenal and McKesson will continue to support OncoHealth’s innovation and delivery of its oncology-specific digital health solutions for people with cancer.